Literature DB >> 23416279

Cyst features and risk of malignancy in intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis.

Neeraj Anand1, Kartik Sampath, Bechien U Wu.   

Abstract

BACKGROUND & AIMS: International guidelines for the management of intraductal papillary mucinous neoplasms (IPMNs) of the pancreas recommend surgical resection of those with specific characteristics. We performed a meta-analysis to evaluate the risk of malignancy associated with each of these features of IPMNs.
METHODS: We performed a comprehensive search of MEDLINE from January 1, 1996, to November 11, 2011, for studies that included any of the features mentioned in the consensus guidelines for surgical resection of main duct and branch duct IPMNs. Data were analyzed from 41 studies for the following features: cyst size greater than 3 cm, the presence of mural nodules, dilated main pancreatic duct, symptoms, and main duct vs branch duct IPMNs. Malignant IPMNs were defined as those with carcinoma in situ or more advanced histology. A separate meta-analysis was performed for each risk factor to calculate pooled odds ratios (ORs). A random-effects model was used, based on the assumption of variation among study populations.
RESULTS: The risks of malignancy associated with individual cyst features were as follows: cyst size greater than 3 cm (OR, 62.4; 95% confidence interval [CI], 30.8-126.3), presence of a mural nodule (OR, 9.3; 95% CI, 5.3-16.1), dilatation of the main pancreatic duct (OR, 7.27; 95% CI, 3.0-17.4), and main vs branch duct IPMN (OR, 4.7; 95% CI, 3.3-6.9). There was a moderate level of heterogeneity among studies (I(2) range, 34-67).
CONCLUSIONS: Based on a meta-analysis, cyst features proposed by the international guidelines for resection of IPMN were highly associated with malignancy. However, based on our findings, not all cyst features should be weighted equally when considering risk of malignancy; cyst size greater than 3 cm was associated most strongly with malignant IPMN.
Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CI; CT; ERCP; EUS; IPMNs; MPD; MRI; OR; Pancreatic Cancer; Pancreatic Tumor; Surgery; Treatment; WHO; World Health Organization; computerized tomography; confidence interval; endoscopic retrograde cholangiopancreatography; endoscopic ultrasound; intraductal papillary mucinous neoplasms; magnetic resonance imaging; main pancreatic duct; odds ratio

Mesh:

Year:  2013        PMID: 23416279     DOI: 10.1016/j.cgh.2013.02.010

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  59 in total

Review 1.  IPMN: surgical treatment.

Authors:  Reto M Käppeli; Sascha A Müller; Bianka Hummel; Christina Kruse; Philip Müller; Jürgen Fornaro; Alexander Wilhelm; Marcel Zadnikar; Bruno M Schmied; Ignazio Tarantino
Journal:  Langenbecks Arch Surg       Date:  2013-09-03       Impact factor: 3.445

Review 2.  To cease or 'de-cyst'? The evaluation and management of pancreatic cystic lesions.

Authors:  Brintha K Enestvedt; Nuzhat Ahmad
Journal:  Curr Gastroenterol Rep       Date:  2013-10

3.  Incidental pancreatic cysts: natural history and diagnostic accuracy of a limited serial pancreatic cyst MRI protocol.

Authors:  Stephanie Nougaret; Caroline Reinhold; Jaron Chong; Laure Escal; Gregoire Mercier; Jean Michel Fabre; Boris Guiu; Nicolas Molinari
Journal:  Eur Radiol       Date:  2014-02-26       Impact factor: 5.315

4.  Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting.

Authors:  Volkan Adsay; Mari Mino-Kenudson; Toru Furukawa; Olca Basturk; Giuseppe Zamboni; Giovanni Marchegiani; Claudio Bassi; Roberto Salvia; Giuseppe Malleo; Salvatore Paiella; Christopher L Wolfgang; Hanno Matthaei; G Johan Offerhaus; Mustapha Adham; Marco J Bruno; Michelle D Reid; Alyssa Krasinskas; Günter Klöppel; Nobuyuki Ohike; Takuma Tajiri; Kee-Taek Jang; Juan Carlos Roa; Peter Allen; Carlos Fernández-del Castillo; Jin-Young Jang; David S Klimstra; Ralph H Hruban
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969

Review 5.  Natural History of Pancreatic Cysts.

Authors:  Alexander Larson; Richard S Kwon
Journal:  Dig Dis Sci       Date:  2017-03-17       Impact factor: 3.199

Review 6.  Imaging Pancreatic Cysts with CT and MRI.

Authors:  R Brooke Jeffrey
Journal:  Dig Dis Sci       Date:  2017-02-20       Impact factor: 3.199

Review 7.  Managing Incidental Pancreatic Cysts.

Authors:  Jennifer Phan; V Raman Muthusamy
Journal:  Curr Gastroenterol Rep       Date:  2018-06-09

Review 8.  Can we better predict the biologic behavior of incidental IPMN? A comprehensive analysis of molecular diagnostics and biomarkers in intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Kiara A Tulla; Ajay V Maker
Journal:  Langenbecks Arch Surg       Date:  2017-12-07       Impact factor: 3.445

Review 9.  Cyst Fluid Biomarkers - Diagnosis and Prediction of Malignancy for Cystic Lesions of the Pancreas.

Authors:  Aadhithya Raman; Anne Marie Lennon
Journal:  Visc Med       Date:  2018-06-13

Review 10.  Management Algorithm for Cystic Pancreatic Lesions.

Authors:  Georg Beyer; Elisabetta Goni; Marlies Köpke; Jan G D'Haese; Jens Werner; Jörg Schirra; Julia Mayerle
Journal:  Visc Med       Date:  2018-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.